Evidence map›Paper›PMID 38865456›Full record

ArticleScience advances2024

Neuroimaging epicenters as potential sites of onset of the neuroanatomical pathology in schizophrenia.

Yuchao Jiang, Lena Palaniyappan, Cheng Luo, Xiao Chang, Jie Zhang, Yingying Tang, Tianhong Zhang, Chunbo Li, Enpeng Zhou, Xin Yu and 12 more

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Distinct Biotypes of Visual Perception in Major Depressive Disorder.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Distinct structural deficits in treatment-resistant schizophrenia and their putative neurotransmitter basis: a source-based morphometry analysis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yuchao JiangInstitute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, PR China.ORCID 0000-0001-7012-0559
Lena PalaniyappanDouglas Mental Health University Institute, Department of Psychiatry, McGill University, Montréal, Quebec, Canada.ORCID 0000-0003-1640-7182
Cheng LuoThe Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of life Science and Technology, University of Electronic Science and Technology of China, Chengdu, PR China.ORCID 0000-0003-0524-5886
Xiao ChangInstitute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, PR China.ORCID 0000-0002-8076-8110
Jie ZhangInstitute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, PR China.ORCID 0000-0002-5016-9192
Yingying TangShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, PR China.ORCID 0000-0002-4705-3682
Tianhong ZhangShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, PR China.ORCID 0000-0002-5379-7119
Chunbo LiShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, PR China.
Enpeng ZhouPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, PR China.
Xin YuPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, PR China.ORCID 0000-0003-3983-4937
Wei LiDepartment of Neurology, West China Hospital, Sichuan University, Chengdu 610041, PR China.
Dongmei AnDepartment of Neurology, West China Hospital, Sichuan University, Chengdu 610041, PR China.ORCID 0000-0003-4622-0837
Dong ZhouDepartment of Neurology, West China Hospital, Sichuan University, Chengdu 610041, PR China.
Chu-Chung HuangShanghai Key Laboratory of Brain Functional Genomics (Ministry of Education), Affiliated Mental Health Center (ECNU), School of Psychology and Cognitive Science, East China Normal University, Shanghai, PR China.ORCID 0000-0002-9096-9610
Shih-Jen TsaiDepartment of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.ORCID 0000-0002-9987-022X
Ching-Po LinInstitute of Neuroscience, National Yang Ming Chiao Tung University, Taipei, Taiwan.ORCID 0000-0001-6848-8776
Jingliang ChengDepartment of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, PR China.ORCID 0000-0002-6996-329X
Jijun WangShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, PR China.
Dezhong YaoThe Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of life Science and Technology, University of Electronic Science and Technology of China, Chengdu, PR China.ORCID 0000-0002-8042-879X
Wei ChengInstitute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, PR China.ORCID 0000-0003-1118-1743
Jianfeng FengInstitute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, PR China.ORCID 0000-0002-8890-8288
ZIB Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia lacks a clear definition at the neuroanatomical level, capturing the sites of origin and progress of this disorder. Using a network-theory approach called epicenter mapping on cross-sectional magnetic resonance imaging from 1124 individuals with schizophrenia, we identified the most likely "source of origin" of the structural pathology. Our results suggest that the Broca's area and adjacent frontoinsular cortex may be the epicenters of neuroanatomical pathophysiology in schizophrenia. These epicenters can predict an individual's response to treatment for psychosis. In addition, cross-diagnostic similarities based on epicenter mapping over of 4000 individuals diagnosed with neurological, neurodevelopmental, or psychiatric disorders appear to be limited. When present, these similarities are restricted to bipolar disorder, major depressive disorder, and obsessive-compulsive disorder. We provide a comprehensive framework linking schizophrenia-specific epicenters to multiple levels of neurobiology, including cognitive processes, neurotransmitter receptors and transporters, and human brain gene expression. Epicenter mapping may be a reliable tool for identifying the potential onset sites of neural pathophysiology in schizophrenia.

Indexed as

Magnetic Resonance ImagingNeuroimagingSchizophreniaAdultBrainBrain MappingFemaleHumansMaleMiddle Aged

Identifiers

PMID38865456
PMCPMC11168466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.